Chugai Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3519400000
JPY
6,857.00
93 (1.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.9 M

Shareholding (Jun 2026)

FII

0.00%

Held by 1 FIIs

DII

100.00%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 23.71%

  • Healthy long term growth as Net Sales has grown by an annual rate of 10.71% and Operating profit at 16.94%
  • Company has very low debt and has enough cash to service the debt requirements
2

With ROE of 25.14%, it has a very attractive valuation with a 6.62 Price to Book Value

3

Majority shareholders : Non Institution

 
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 12,267,195 Million (Large Cap)

stock-summary
P/E

26.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.02%

stock-summary
Debt Equity

-0.45

stock-summary
Return on Equity

25.14%

stock-summary
Price to Book

6.43

Revenue and Profits:
Net Sales:
341,584 Million
(Quarterly Results - Jun 2026)
Net Profit:
116,331 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.29%
0%
-15.29%
6 Months
-20.34%
0%
-20.34%
1 Year
-7.34%
0%
-7.34%
2 Years
11.1%
0%
11.1%
3 Years
64.16%
0%
64.16%
4 Years
81.88%
0%
81.88%
5 Years
71.38%
0%
71.38%

Chugai Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
10.71%
EBIT Growth (5y)
16.94%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
0.64
Tax Ratio
27.32%
Dividend Payout Ratio
103.14%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
55.96%
ROE (avg)
23.71%

Valuation key factors

Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
6.62
EV to EBIT
18.08
EV to EBITDA
16.83
EV to Capital Employed
11.14
EV to Sales
9.12
PEG Ratio
1.68
Dividend Yield
0.03%
ROCE (Latest)
61.60%
ROE (Latest)
25.14%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 6.17% vs -7.09% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.79% vs -10.12% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "341,584.00",
          "val2": "321,747.00",
          "chgp": "6.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "175,367.00",
          "val2": "171,469.00",
          "chgp": "2.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5,000.00",
          "val2": "-4,500.00",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "116,331.00",
          "val2": "115,418.00",
          "chgp": "0.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "484.70%",
          "val2": "505.60%",
          "chgp": "-2.09%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.46% vs 5.33% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 12.06% vs 19.00% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,257,941.00",
          "val2": "1,170,611.00",
          "chgp": "7.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "624,442.00",
          "val2": "575,572.00",
          "chgp": "8.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "433.00",
          "val2": "95.00",
          "chgp": "355.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-27,566.00",
          "val2": "-8,992.00",
          "chgp": "-206.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "434,012.00",
          "val2": "387,317.00",
          "chgp": "12.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "470.50%",
          "val2": "464.60%",
          "chgp": "0.59%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
341,584.00
321,747.00
6.17%
Operating Profit (PBDIT) excl Other Income
175,367.00
171,469.00
2.27%
Interest
0.00
0.00
Exceptional Items
-5,000.00
-4,500.00
-11.11%
Consolidate Net Profit
116,331.00
115,418.00
0.79%
Operating Profit Margin (Excl OI)
484.70%
505.60%
-2.09%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 6.17% vs -7.09% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 0.79% vs -10.12% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,257,941.00
1,170,611.00
7.46%
Operating Profit (PBDIT) excl Other Income
624,442.00
575,572.00
8.49%
Interest
433.00
95.00
355.79%
Exceptional Items
-27,566.00
-8,992.00
-206.56%
Consolidate Net Profit
434,012.00
387,317.00
12.06%
Operating Profit Margin (Excl OI)
470.50%
464.60%
0.59%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 7.46% vs 5.33% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 12.06% vs 19.00% in Dec 2024

stock-summaryCompany CV
About Chugai Pharmaceutical Co., Ltd. stock-summary
stock-summary
Chugai Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available